Drug ‘new hope’ for breast cancer

A breast cancer treatment to be trialled in Ireland brings fresh hope to women with a particularly aggressive form of the disease that is resistant to current therapies.

Irish researchers have found that a new type of cancer drug, Copanlisib, acts as a signal blocker in cancer cells. A clinical trial will get under way later this year, with patients recruited through their consultant.

The drug, developed by Bayer, holds the promise of stopping the growth and spread of cancer cells when used in combination with standard therapies.